LIVN News and Press, LivaNova PLC From 02/26/20

The following slide deck was published by LivaNova PLC in conjunction with their 2019 Q4 earnings Read more ...

LivaNova PLC (NASDAQ: LIVN ): Q4 Non-GAAP EPS of $1.00 beats by $0.02 ; GAAP EPS of -$2.96 misses by $3.64 . More news on: LivaNova PLC, Earnings news and commentary, Healthcare stocks news, Read more ...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2019. For the fourth quarter of 2019, worldwide sales were $287.6 million, a decrease of 3.2 percent on a reported basis and a de...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for a device modification to its 3T Heater-Cooler ® devices. The modification includes the installation of a 3T Ae...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, commends the recent international consensus statement published in the Journal of Affective Disorders for recommendations to identify, assess and manage depression for patients unable to achieve or susta...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2019 results on Wednesday, Feb. 26, 2020 at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its fourth qu...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will present new registry data from two patient populations benefiting from Vagus Nerve Stimulation Therapy ® (VNS Therapy) at the American Epilepsy Society 2019 Annual Meeting , ...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it is ending its Caisson Transcatheter Mitral Valve Replacement (TMVR) program and will undertake a restructuring of its heart valve business to improve profitability and ensure business co...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Thad Huston, Chief Financial Officer, will participate in discussions at the Berenberg European Conference 2019 in London and at the Piper Jaffray 31st Annual Healthcare Conference in New York. The di...

LivaNova PLC (LIVN) Q3 2019 Earnings Conference Call October 30, 2019, 08:00 ET Company Participants Matthew Dodds - SVP, Corporate Development Damien McDonald - CEO & Director Thad Huston - CFO Conference Call Participants Rajbir Denhoy - Jefferies Rick Wise - Stifel...